24/7 Patient Assistance: 760-405-8205

Sang Ahn, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Ahn graduated the medical school from the Seoul National University College of Medicine and completed his residency and fellowship programs at the University of Arizona. He is specialized and board certified in Oncology. Dr. Ahn has been in practice for more than 20 years and is affiliated with the Corona Regional Medical Center. During his career, he has also contributed to 7 publications of medical interest.

  • Education & Training


    Seoul National University College of Medicine

    Medical School


    University of Arizona



    University of Arizona


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Corona Regional Medical Center

    Languages: English/Spanish

    (951) 737-4343

    800 S Main St

    Corona, California 92882

    Read More

    Orange Coast Memorial Medical Center

    Languages: English/Spanish

    (714) 378-7000

    9920 Talbert Ave

    Fountain Valley, California 92708

    Read More

    Parkview Community Hospital Medical Center

    Languages: English/Spanish

    (951) 688-2211

    3865 Jackson St

    Riverside, California 92503

    Read More

    Riverside Community Hospital

    Languages: English/Spanish

    (951) 788-3000

    4445 Magnolia Ave

    Riverside, California 92501

    Read More
  • Publications & Memberships

    Dr. Sang Ahn has contributed to 3 publications.

    Cell culture-adaptive mutations of NS5A affect replication of hepatitis C virus differentially depending on the viral genotypes.

    Chung A, Jin B, Han K, Ahn SH, Kim S; J. Med. Virol.. 2017-01-01.

    See more >>

    Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adef...

    Kim MN, Park JY, Ahn SH, Kim BK, Kim SU, Kim DY, Han K; J. Med. Virol.. 2017-01-01.

    See more >>

    Rapamycin-insensitive companion of mTOR (RICTOR) Amplification Defines a Subset of Advanced Gastric Cancer and is Sensitive to AZD2014-mediated mTORC1/2 Inhibition.

    Kim ST, Kim SY, Klempner SJ, Yoon J, Kim N, Ahn S, Bang H, Kim K, Park W, Park SH, Park JO, Park YS, Lim HY, Lee SH, Park K, Kang WK, Lee J; Ann. Oncol.. 2016-12-27.

    See more >>